Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Adalimumab biosimilar performs well in chronic plaque psoriasis treatment
16 Sep 2022
The adalimumab biosimilar BI 695501 has demonstrated equivalent pharmacokinetics to the reference product, with highly comparable efficacy, immunogenicity, and safety in patients with chronic plaque psoriasis, according to data from the phase III VOLTAIRE-X trial.
16 Sep 2022

Older age, itch, pain predict depression in atopic dermatitis
15 Sep 2022
Depressive symptoms are common among adults with atopic dermatitis (AD) severity and may fluctuate over time, reveals a study. Persistent depression is significantly associated with older age, male sex, severe itch, and skin pain, among others.
15 Sep 2022






